The relationship between heart rate variability and serum cytokines in chronic chagasic patients with persistent

Mauricio Llaguno1, Luiz Antonio Rodrigues de Resende Pertili, Marcos Vinicius da Silva

  • 1Internal Medicine Department, Infectious Division, Federal University of the Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.

Insights

Chagas

Area of Science:

  • Cardiology
  • Immunology
  • Infectious Diseases

Background:

  • Persistent parasitemia and immune system dysfunction contribute to chronic Chagas' disease cardiovascular complications.
  • Autonomic nervous system impairments are implicated in the progression of Chagas' disease.
  • Understanding these factors is crucial for managing the chronic phase of Chagas' disease.

Purpose of the Study:

  • To investigate autonomic nervous system function and serum cytokine profiles in patients with different forms of chronic Chagas' disease.
  • To assess cardiovascular risk associated with autonomic dysfunction and immune markers.
  • To differentiate between indeterminate and cardiac forms of Chagas' disease.

Main Methods:

  • Evaluated 17 indeterminate (IChD) and 12 cardiac (ChHD) chronic Chagas' disease patients, plus 29 controls.
  • Assessed parasitemia, heart rate variability (linear and nonlinear methods), and serum cytokines (ILs, TNF-α, IFN-γ).
  • Utilized polymerase chain reaction, hemoculture, and enzyme-linked immune assay for analyses.

Main Results:

  • Chagasic patients exhibited reduced heart rate variability compared to controls.
  • Nonlinear heart rate variability indices indicated higher impairment in the cardiac (ChHD) group.
  • ChHD patients showed elevated IL-10 and reduced IFN-γ levels compared to the indeterminate (IChD) group.

Conclusions:

  • Both chagasic groups display autonomic dysfunction via linear heart rate variability analysis.
  • Nonlinear analysis suggests increased cardiovascular risk in the cardiac Chagas' disease group.
  • Distinct cytokine profiles (higher IL-10, lower IFN-γ) in ChHD patients suggest immune regulation processes.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...